This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Time To Buy The Fear Dip?
by Daniel Laboe
Innovation's capitulation may be sold out as high-growth bears run out of selling fuel, leaving the door wide open for stock pickers to get into their favorite next-gen stocks
Veeva Systems (VEEV) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Veeva (VEEV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veeva Systems (VEEV) Vault CDMS to Aid Idorsia's Clinical Trials
by Zacks Equity Research
Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Veeva Development Cloud business.
Cloudflare (NET) Reports Break-Even Earnings for Q4
by Zacks Equity Research
Cloudflare (NET) delivered earnings and revenue surprises of 100% and 4.77%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Veeva Systems (VEEV)-LYSARC Partner to Advance Lymphoma Therapy
by Zacks Equity Research
Veeva Systems' (VEEV) Veeva Development Cloud will allow LYSARC to develop innovative lymphoma therapies or enhance current therapies.
Veeva (VEEV) Stock Jumps 3.6%: Will It Continue to Soar?
by Zacks Equity Research
Veeva (VEEV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Why Is Veeva (VEEV) Down 0.9% Since Last Earnings Report?
by Zacks Equity Research
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Veeva's (VEEV) Data Cloud to Aid PharmaEssentia's New Product
by Zacks Equity Research
Adoption of Veeva Systems' (VEEV) cloud applications is likely to significantly boost its Commercial Cloud business.
Here's Why You Should Retain Veeva Systems (VEEV) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Veeva Systems (VEEV) owing to its strong product portfolio.
Veeva Systems' (VEEV) Buyout to Bolster Clinical Offering
by Zacks Equity Research
Veeva Systems' (VEEV) Veracity Logic buyout can help companies to simplify complex processes and speed up clinical trials.
Can Veeva (VEEV) Stock Continue to Grow Earnings?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Veeva (VEEV).
Veeva Systems (VEEV) Q3 Earnings Beat Estimates, '22 View Up
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal Q3 results reflect impressive performances by both its segments.
Veeva Systems (VEEV) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Veeva (VEEV) delivered earnings and revenue surprises of 10.23% and 2.32%, respectively, for the quarter ended October 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Alphabet, Cadence Design Systems, Veeva Systems, Mettler-Toledo and ANSYS
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Cadence Design Systems, Veeva Systems, Mettler-Toledo and ANSYS
Buy This Tech Stock on the Dip Before Earnings for Big Growth?
by Benjamin Rains
VEEV is trading nearly 15% below its records heading into its Q3 earnings release that's due out after the closing bell on Wednesday, December 1...
Black Friday on Global Bourses: 5 Picks to Protect Portfolio
by Nalak Das
We have selected five large-cap (market capital > $30 billion) technology stocks to invest. These are: GOOGL, VEEV, ANSS, MTD and CDNS.
Veeva Systems (VEEV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Veeva (VEEV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veeva Systems (VEEV) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Veeva Systems' (VEEV) fiscal third-quarter results are likely to reflect solid show by its segments and robust product portfolio.
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $288.42, marking a -1.24% move from the previous day.
Veeva Systems (VEEV) Digital Tools Boost Patient Engagement
by Zacks Equity Research
Veeva Systems' (VEEV) enhancements in digital tools incorporate new ways for seamless communication among healthcare providers and field teams.
Veeva Systems (VEEV) Vault Quality Suite Gets Adopted by CBM
by Zacks Equity Research
Veeva Systems' (VEEV) product gets adopted by CBM. This can drive the development and delivery of groundbreaking treatments for patients.
Veeva Systems (VEEV) Stock Moves -0.67%: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed the most recent trading day at $315.54, moving -0.67% from the previous trading session.
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Veeva Systems (VEEV) closed at $320.45 in the latest trading session, marking a +0.51% move from the prior day.
Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $314.81, marking a -0.69% move from the previous day.
Veeva Systems (VEEV) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Veeva Systems (VEEV) closed at $322.99, marking a +0.42% move from the previous day.